# Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010)

> **NCT01092780** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 56 (actual)

## Conditions studied

- Apnea, Sleep

## Interventions

- **DRUG:** MK-7288
- **DRUG:** Placebo to MK-7288
- **DRUG:** Modafinil
- **DRUG:** Placebo to modafinil

## Key facts

- **NCT ID:** NCT01092780
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-26
- **Primary completion:** 2011-05-31
- **Final completion:** 2011-05-31
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01092780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01092780, "Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01092780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*